Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects.

作者: M Soledad Cepeda , Hernando Alvarez , Olga Morales , Daniel B Carr

DOI: 10.1016/J.PAIN.2003.09.011

关键词:

摘要: Ultralow doses of naloxone (0.001-0.1 microg/kg) produce analgesia in animal models. However, no clinical study has evaluated the combination ultralow dose and morphine using patient-controlled (PCA). This randomized, double blind controlled sought to determine if PCA solutions affects opioid requirements, analgesia, side effects. Two-hundred sixty-five patients (18-65 years old) undergoing operations were randomized receive 1 mg/ml (n=129) or plus 0.6 microg/ml (n=136). We numbers supplemental rescue doses, cumulative each solution, pain intensity, relief, effects during first 24 h after surgery. found that requirements did not differ significantly between groups. The morphine+naloxone group on average required 0.07 mg more (95% CI -1.1 1.3) than group. Pain intensity levels also similar both had 0.06 units lower -0.5 0.4) a incidence nausea pruritus (P=0.01 for symptoms). vomiting, time tolerate fluids, sedation, urinary retention groups (all P values >0.1). does affect but it decreases pruritus.

参考文章(21)
Scott L. Zeger, Kung-Yee Liang, Paul S. Albert, Models for longitudinal data: a generalized estimating equation approach. Biometrics. ,vol. 44, pp. 1049- 1060 ,(1988) , 10.2307/2531734
David G. Silverman, Jay Freilich, Ferne B. Sevarino, Darcy Paige, Linda Preble, Theresa Z. O??Connor, Influence of promethazine on symptom-therapy scores for nausea during patient-controlled analgesia with morphine. Anesthesia & Analgesia. ,vol. 74, pp. 735- 738 ,(1992) , 10.1213/00000539-199205000-00019
Soledad M. Cepeda, Juan M. Africano, Ana M. Manrique, Wilmer Fragoso, Daniel B. Carr, The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period Pain. ,vol. 96, pp. 73- 79 ,(2002) , 10.1016/S0304-3959(01)00425-0
Girish P. Joshi, Larry Duffy, Jamal Chehade, Jay Wesevich, Noor Gajraj, Edward R. Johnson, Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology. ,vol. 90, pp. 1007- 1011 ,(1999) , 10.1097/00000542-199904000-00013
Hiroshi Ueda, Nobuyuki Fukushima, Tadaaki Kitao, Ming Ge, Hiroshi Takagi, Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neuroscience Letters. ,vol. 65, pp. 247- 252 ,(1986) , 10.1016/0304-3940(86)90269-7
Blythe B. Holmes, James M. Fujimoto, Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice. Anesthesia & Analgesia. ,vol. 77, pp. 1166- 1173 ,(1993) , 10.1213/00000539-199312000-00015
Ewan McNicol, Nathalie Horowicz-Mehler, Ruth A Fisk, Kyle Bennett, Maria Gialeli-Goudas, Priscilla W Chew, Joseph Lau, Daniel Carr, Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review The Journal of Pain. ,vol. 4, pp. 231- 256 ,(2003) , 10.1016/S1526-5900(03)00556-X
M. Soledad Cepeda, Martha Delgado, Marion Ponce, Carlos A. Cruz, Daniel B. Carr, Equivalent Outcomes During Postoperative Patient-Controlled Intravenous Analgesia with Lidocaine Plus Morphine Versus Morphine Alone Anesthesia & Analgesia. ,vol. 83, pp. 102- 106 ,(1996) , 10.1097/00000539-199607000-00018
Christopher R. France, Shannon Suchowiecki, A comparison of diffuse noxious inhibitory controls in men and women Pain. ,vol. 81, pp. 77- 84 ,(1999) , 10.1016/S0304-3959(98)00272-3